geoscience.net logo
+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Effects of 2-hydroxyestradiol-17 beta, 2-hydroxyestradiol-17 alpha, and 4-hydroxyestrone on the preovulatory luteinizing hormone surge in the rat: agonist and antagonist actions


, : Effects of 2-hydroxyestradiol-17 beta, 2-hydroxyestradiol-17 alpha, and 4-hydroxyestrone on the preovulatory luteinizing hormone surge in the rat: agonist and antagonist actions. Endocrinology 115(3): 1090-1094

Four-day cycling rats equipped with intracardiac catheters were injected with 2-hydroxyestradiol-17 beta (2OHE2-17 beta) at 0800, 0900, 1000, and 1200 h on the morning of proestrus. The administration at 0800 and 0900 h resulted in abolition of the afternoon preovulatory LH surge in virtually all animals. Injections given at 1000 and 1200 h were ineffective in this respect. The isomeric catechol estrogen 4-hydroxyestrone effectively inhibited the LH surge when given at 0900 h, but not if injected at 1000 or 1200 h. In contrast, the nonestrogenic 2-hydroxyestradiol-17 alpha was effective in blocking the LH surge when given at 0900 or 1000 h. Rats treated with 2OHE2-17 beta at 1000 h responded normally to exogenous LHRH administration in the afternoon, indicating that the action of 2OHE2-17 beta is at the hypothalamic level. 2OHE2-17 beta and 4-hydroxyestrone, which are potent estrogens, may act in this instance first as estrogen agonists, advancing the "time window" when their catechol antagonist properties in blocking the LH surge can be functional. The nonuterotropic 2-hydroxyestradiol-17 alpha and 2-hydroxyestrone act solely as catechol estrogens and inhibit the preovulatory LH surge if administered at a time when they be present during this physiological window, which is thought to involve events at the estrogen-catecholaminergic interphase.

US$19.90

PMID: 6540166

DOI: 10.1210/endo-115-3-1090


Other references

Savich, V.I.; Krutilina, V.S.; Egorov, D.N.; Kashansky, A.D., 2004: Objective characteristic of soils colour using computer diagnosis. Objective characteristic of colour of soils profile, samples and soil smears in field diaries with the use of computer diagnosis in Adobe Photoshop in systems CIE-Lab. RGB and CMYK with scanning coloured photographs, soil smears, negatives of phot...

Anonymous, 2006: 8th Indian Agricultural Scientists and Farmer's Congress, 21-22 February, 2006. Abstracts of 342 papers from the title congress are presented. Different disciplines of agricultural science, including crop production, crop protection, animal husbandry, dairy technologies, fisheries, biochemistry and biotechnology, agricultural...

Kurahachi H.; Moridera K.; Ishihara T.; Waseda N.; Kasakura S.; Igarashi T.; Masaka M.; Iwamaru H., 1987: Clinical usefulness of serum fructosamine levels in diabetes. Serum fructosamine (FRS) levels in diabetics were measured by the Roche "Fructosamine" test. The average basal FRS level was 2.56 .+-. 0.23 (m .+-. SD) in the healthy controls (n = 395) 3.37 .+-. 0.42 in one group of diabetics (HbA1 .lto...

Affonso, D.D.; Hurst, I.; Mayberry, L.J.; Haller, L.; Yost, K.; Lynch, M.E., 1992: Stressors reported by mothers of hospitalized premature infants. Neonatal Network 11(6): 63-70

Bierkamp, C.; Mclaughlin, K.J.; Schwarz, H.; Huber, O.; Kemler, R., 1996: Embryonic heart and skin defects in mice lacking plakoglobin. Plakoglobin is the only component common to both the desmosomal plaque and the cadherin-catenin cell adhesion complex in the adherens junction. It is highly homologous to vertebrate beta-catenin and to Drosophila armadillo protein and may sbd like...

Ergüven, S., 1986: Myasthenia gravis and autoimmunity. A disorder in immune system is thought to be the factor in Myasthenia gravis. Certain antibodies against various tissues have been detected in the sera of this group of patients. Anti-acetyl-cholin receptor antibodies are positive in 90% of the pa...

Palmieri, B.; Sblendorio, V.; Ferrari, A.; Pietrobelli, A., 2007: Duchenne muscle activity evaluation and muscle function preservation: is it possible a prophylactic strategy?. Duchenne muscular dystrophy yields pervasive and progressive muscle mass loss. In the current measures relating to the monitoring of disease progression the following are relevant (i): the type of scale used, (ii) the clinical significance of the...

Cramer, S.D.; Porter, K.L.; Rochat, M.C.; Lamm, C.G., 2012: Pathology in practice. Liposarcoma. Journal of the American Veterinary Medical Association 239(6): 757-759

Chen, G-Jing.; Wang, L-Fang., 2012: Design of magnetic nanoparticles-assisted drug delivery system. Magnetic nanoparticles (MNPs) have been designed for multifaceted applications such as contrast agents in magnetic resonance imaging (MRI) diagnosis, drug/gene carriers for different kinds of therapeutic agents, tissue repair, hyperthermia, immuno...

Paracka, L.; Wegner, F.; Blahak, C.; Abdallat, M.; Saryyeva, A.; Dressler, D.; Karst, M.; Krauss, J.K., 2017: Sensory Alterations in Patients with Isolated Idiopathic Dystonia: An Exploratory Quantitative Sensory Testing Analysis. Abnormalities in the somatosensory system are increasingly being recognized in patients with dystonia. The aim of this study was to investigate whether sensory abnormalities are confined to the dystonic body segments or whether there is a wider in...